Cystic Fibrosis

For people with CF, their caregivers, loved ones, and clinicians, click through summaries of 10 well-established sources of support for all aspects of the condition.

Measures used to assess medication adherence in cystic fibrosis patients may overestimate use of therapy, according to results of a new study.

Authors of a recent review of CF-specific care support technology advise that if the technology adds to treatment burden, it won't be effective.

The burden of poor mental health among CF patients is significant and impacts all aspects of disease management. Test yourself on international best practices for screening and treatment. 

Depression in people with cystic fibrosis is 2 times higher than in the general population and among their caretakers, 3 times higher. The toll on treatment adherence is significant.

Part II on CF medication adherence solutions at Fairview Health Services focuses on how the specialty pharmacy staff helps patients better manage barriers.

Cystic fibrosis medication adherence rates at Fairview Health Services in Minneapolis are 70% higher than at retail pharmacies. Patient Care found out why. Interview, here.

Trikafta™ is the first triple combination therapy approved for the treatment of the most common cystic fibrosis mutation. 

Rates of adherence to cystic fibrosis treatment plans have been reported as low as 36%. The motivational interviewing approach could help, according to MI trainer Ellen R. Glovsky, PhD, RD, LDN.

Motivational interviewing uses the common human problem of ambivalence about change to help clients shape their own solutions.

Cystic fibrosis treatment guidelines must evolve to keep pace with new treatments and disease knowledge. Try 7 questions on the latest iteration.

Pilot study success with a new cystic fibrosis treatment adherence tool may augur similar positive results from current RCT. Outcomes are due, soon.